An Update on Inhibitors of Human 14 kDa Type II s PLA2 in Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|7|3|181-198

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.7, Iss.3, 2001-02, pp. : 181-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial [Hot Topic: Phospholipase Inhibition: Medicinal Chemistry and Therapeutic Potential of PLA2 Inhibitors (Guest Editor: Dr. K.S. Rangappa)]

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 8, 2007-04 ,pp. : 741-742

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon-α2a (40 kDa) for chronic hepatitis C

By Hadziyannis Stephanos J   Papatheodoridis George V  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 4, 2003-04 ,pp. : 541-551

Informa Healthcare

Access to resources Recommend Favorite

3D QSAR Study of Human PLA2 Inhibitors. A Modeling Approach to Select New and Specific Anti-Inflammatory Drugs

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 2, 2006-01 ,pp. : 175-187

Bentham Science Publishers

Access to resources Recommend Favorite

An Update in the Development of HIV Entry Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 13, 2007-07 ,pp. : 1273-1289

Bentham Science Publishers

Access to resources Recommend Favorite

90-kDa S6 kinase is insufficient or not involved in the activation of glycogen synthase induced by insulin

By Yasui K.   Niki I.   Hidaka H.  

European Journal of Pharmacology, Vol. 316, Iss. 2, 1996-12 ,pp. : 317-323

Elsevier

Access to resources Recommend Favorite